This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: Donna L Rudolph: Innovator in HTLV-I Associated Myelopathy Diagnosis
Introduction
Donna L Rudolph is a notable inventor based in Tucker, GA (US). She has made significant contributions to the field of medical diagnostics, particularly in relation to HTLV-I associated myelopathy. Her innovative work has led to the development of methods and compositions that aid in the diagnosis of this condition.
Latest Patents
Donna L Rudolph holds 1 patent for her invention titled "Methods and compositions for diagnosing HTLV-I associated myelopathy." This invention provides antigenic peptides derived from immunodominant epitopes of the HTLV-I tax or rex proteins. These peptides are immunoreactive with antibodies associated with disease in HTLV-I infected subjects. The invention outlines a method for diagnosing HTLV-I associated myelopathy (HAM) or a predisposition to it, which involves contacting an antibody-containing sample from the subject with a detectable amount of the peptide and detecting the reaction. Additionally, it provides a method for diagnosing adult T-cell leukemia or a predisposition to it.
Career Highlights
Donna L Rudolph is affiliated with the United States of America as represented by the Department of Health. Her work has been instrumental in advancing the understanding and diagnosis of HTLV-I related diseases.
Collaborations
One of her notable collaborators is Renu B Lal, who has worked alongside her in the development of these diagnostic methods.
Conclusion
Donna L Rudolph's contributions to medical diagnostics, particularly in the area of HTLV-I associated myelopathy, highlight her innovative spirit and dedication to improving health outcomes. Her work continues to influence the field and offers hope for better diagnostic methods in the future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
